Identifying molecular markers for the early detection of pancreatic neoplasia

Semin Oncol. 2007 Aug;34(4):303-10. doi: 10.1053/j.seminoncol.2007.05.003.


Pancreatic cancer is the fourth most common cause of cancer death in the United States. There is a great need for better diagnostic markers of pancreatic neoplasia. Better markers would improve the early diagnosis of pancreatic cancer and allow more patients to undergo curative surgical resection. Identifying individuals at high risk of developing pancreatic cancer and applying markers that could identify precancerous lesions of the pancreas in these individuals could allow such lesions to be resected before the development of pancreatic cancer. As we continue to characterize the genetic, epigenetic, and proteomics alterations that occur in pancreatic cancers and their percursors, better diagnostic markers of pancreatic cancer are expected to follow.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Carcinoma, Pancreatic Ductal / diagnosis*
  • Carcinoma, Pancreatic Ductal / genetics
  • Early Diagnosis
  • Genetic Markers
  • Humans
  • MicroRNAs / chemistry
  • Pancreatic Juice / chemistry
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / genetics
  • Proteomics
  • Risk


  • Biomarkers, Tumor
  • Genetic Markers
  • MicroRNAs